Group 1: Zacks Premium Overview - Zacks Premium offers various tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1] - The service aims to help investors become more confident and informed in their investment decisions [1] Group 2: Zacks Style Scores - Zacks Style Scores are complementary indicators that rate stocks based on value, growth, and momentum methodologies, assisting investors in selecting stocks likely to outperform the market in the next 30 days [2] - Each stock receives a rating from A to F, with A indicating the highest potential for outperformance [3] Group 3: Value Score - The Value Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow [3] Group 4: Growth Score - The Growth Score evaluates a company's financial health and future outlook by analyzing projected and historical earnings, sales, and cash flow [4] Group 5: Momentum Score - The Momentum Score is designed for traders who capitalize on price trends, utilizing factors like one-week price changes and monthly earnings estimate changes [5] Group 6: VGM Score - The VGM Score combines Value, Growth, and Momentum Scores, providing a comprehensive indicator for stock selection alongside the Zacks Rank [6] Group 7: Zacks Rank and Performance - The Zacks Rank is a proprietary model that uses earnings estimate revisions to identify stocks, with 1 (Strong Buy) stocks achieving an average annual return of +23.75% since 1988, significantly outperforming the S&P 500 [7] - There can be over 800 top-rated stocks available, making it essential for investors to utilize Style Scores for better selection [8] Group 8: Stock Example - Medtronic (MDT) - Medtronic, Inc. is currently rated 3 (Hold) on the Zacks Rank with a VGM Score of B, following its acquisition of Covidien for $49.9 billion in 2015 [11] - MDT has a Momentum Style Score of A, with a recent share price increase of 0.1% over the past four weeks, and 11 analysts have revised earnings estimates higher for fiscal 2026 [12]